3‐phosphoinositide‐dependent protein kinase 1 (PDK1) mediates crosstalk between Src and Akt pathways in MET receptor signaling
Authors:
Open Access
- 22 September 2021
- journal article
- research article
- Published by Wiley in FEBS Letters
- Vol. 595 (21) , 2655-2664
Abstract
The high‐affinity tyrosine kinase receptor MET plays a pivotal role in several facets of cell regulation. Although its mitogenic effect is well documented, some aspects of connection patterns between signaling pathways involved in cell cycle progression remain to be deciphered. We have used a tractable heterologous expression system, the Xenopus oocyte, to detect connections between distinct MET signaling cascades involved in G2/M progression. Our results reveal that Src acts as an adapter via its SH2 domain to recruit 3‐phosphoinositide‐dependent protein kinase 1 (PDK1) to the MET signaling complex leading to Akt phosphorylation. These data define an original crosstalk between Src and Akt signaling pathways that contributes to MET‐induced entry into the M phase, and deserves further investigation in pathologies harboring deregulation of this receptor.Keywords
This publication has 43 references indexed in Scilit:
- Loss of c-Met Disrupts Gene Expression Program Required for G2/M Progression during Liver Regeneration in MicePLOS ONE, 2010
- Down-Regulation of the Met Receptor Tyrosine Kinase by Presenilin-dependent Regulated Intramembrane ProteolysisMolecular Biology of the Cell, 2009
- Role of Src Signal Transduction Pathways in Scatter Factor-mediated Cellular ProtectionJournal of Biological Chemistry, 2009
- Cell growth, global phosphotyrosine elevation, and c-Met phosphorylation through Src family kinases in colorectal cancer cellsProceedings of the National Academy of Sciences, 2008
- A novel activating role of SRC and STAT3 on HGF transcription in human breast cancer cellsMolecular Cancer, 2007
- Gab1 Is Required for Cell Cycle Transition, Cell Proliferation, and Transformation Induced by an Oncogenic Met ReceptorMolecular Biology of the Cell, 2006
- A novel activating function of c-Src and Stat3 on HGF transcription in mammary carcinoma cellsOncogene, 2006
- Src Is an Important Mediator of Extracellular Signal–Regulated Kinase 1/2–Dependent Growth Signaling by Angiotensin II in Smooth Muscle Cells From Resistance Arteries of Hypertensive PatientsHypertension, 2001
- Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase InhibitorJournal of Biological Chemistry, 1996
- Induction by NGF of Meiotic Maturation of Xenopus Oocytes Expressing the trk Proto-Oncogene ProductScience, 1991